Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179
In the original publication [...]
Main Authors: | Tâmara Dauare de Almeida, Fernanda Cristina Gontijo Evangelista, Adriano de Paula Sabino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Future Pharmacology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9879/3/3/36 |
Similar Items
-
Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity
by: Tâmara Dauare de Almeida, et al.
Published: (2023-02-01) -
No PL in APL: No Perception of Light in Acute Promyelocytic leukemia
by: Dina Laimon, et al.
Published: (2024-06-01) -
Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3
by: Ji-Hea Kim, et al.
Published: (2022-08-01) -
Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
by: Alexandra Ghiaur, et al.
Published: (2023-06-01) -
ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS
by: Anna Maria Testi, et al.
Published: (2014-04-01)